W. J. Boyle
Oncology · 2000–2012
A researcher in the Science corpus: 9 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 29 citations into it; #917 of 1,698 by trust here, #409 by citations
- Molecular Biology — 23 citations into it; #11,479 of 17,773 by trust here, #4,000 by citations
- Orthopedics and Sports Medicine — 9 citations into it
Whom W. J. Boyle trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts W. J. Boyle overall
- Hiroshi Takayanagi
- R. Darveau
- B. Clarke
- R. Baron
- S. Khosla
- P. Italiani
- Osbjorn M. Pearson
- G. Gupta
- K. Bedard
- R. Stout
Papers from W. J. Boyle's perspective
Ordered by how strongly the researchers W. J. Boyle trusts endorse each paper. Same corpus, a different order for every researcher.
- Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. (Endocrine reviews)
- Therapeutic approaches to bone diseases. (Science)
- Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. (Journal of Clinical Investigation)
- RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β (Nature)
- The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone Resorption (Journal of Bone and Mineral Research)
- Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. (Developmental Cell)
- The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. (Experimental Cell Research)
- TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. (Journal of Clinical Investigation)
- Bone resorption by osteoclasts. (Science)
- Distinct molecular mechanism for initiating TRAF6 signalling (Nature)
Their papers
- Osteoclast differentiation and activation (2003) — 6,592 citations
- The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. (2000) — 776 citations
- The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone Resorption (2000) — 1,205 citations
- RANK-L and RANK: T cells, bone loss, and mammalian evolution. (2002) — 843 citations
- Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. (2003) — 804 citations
- Osteoprotegerin Reverses Osteoporosis by Inhibiting Endosteal Osteoclasts and Prevents Vascular Calcification by Blocking a Process Resembling Osteoclastogenesis (2000) — 599 citations
- Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab (2012) — 645 citations
- Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. (2000) — 634 citations
- RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. (2000) — 1,176 citations